STIM Christopher Thatcher sells $252K worth of shares
Jan 02, 2026, 11:41 PM
0.00%
What does STIM do
Neuronetics, based in Malvern, Pennsylvania, develops the NeuroStar Advanced Therapy System, a TMS device for treating major depressive disorder. The company went public on June 28, 2018, and employs 202 people.
Christopher Thatcher sold 15,000 shares of STIM on 8 April at $16.82 per share, worth a total of $252K. They now own 54,811 STIM shares, or a 21% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.